Sign up to save your podcasts
Or
Share Human Insight Plus AI: A Winning Combination For Drug Development with Liesbeth Ceelen, CEO, and Arjan van Manen, Commercial Director of BioLizard
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Human Insight Plus AI: A Winning Combination For Drug Development with Liesbeth Ceelen, CEO, and Arjan van Manen, Commercial Director of BioLizard
This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to outcomesrocket.com
The crucial combination of human expertise and AI is paramount for success in drug development.
In this episode, Liesbeth Ceelen, CEO, and Arjan van Manen, Commercial Director of BioLizard, discuss the critical role of data analytics and machine learning in the pharmaceutical industry, highlighting the increasing need for companies to become data-driven. They emphasize how a deep understanding of biology, supported by AI, can optimize target discovery and reduce clinical trial failures. BioLizard offers the expertise and a platform to support biotech and pharma companies in this new data-driven approach as the industry shifts from viewing data analysis as a cost to a necessity for better outcomes. Finally, they touch upon predictions for 2025, focusing on a more data-supported approach to drug development, tailored treatments, and a heightened focus on target mechanisms while remaining optimistic about the changing mindset of industry stakeholders.
Tune in and learn how data analytics can transform your approach to drug development!
Fast Track Your Business Growth:
Outcomes Rocket is a full service marketing agency focused on helping healthcare organizations like yours maximize your impact and accelerate growth. Learn more at outcomesrocket.com
View all episodes
By Saul Marquez
4.9
110110 ratings
This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to outcomesrocket.com
The crucial combination of human expertise and AI is paramount for success in drug development.
In this episode, Liesbeth Ceelen, CEO, and Arjan van Manen, Commercial Director of BioLizard, discuss the critical role of data analytics and machine learning in the pharmaceutical industry, highlighting the increasing need for companies to become data-driven. They emphasize how a deep understanding of biology, supported by AI, can optimize target discovery and reduce clinical trial failures. BioLizard offers the expertise and a platform to support biotech and pharma companies in this new data-driven approach as the industry shifts from viewing data analysis as a cost to a necessity for better outcomes. Finally, they touch upon predictions for 2025, focusing on a more data-supported approach to drug development, tailored treatments, and a heightened focus on target mechanisms while remaining optimistic about the changing mindset of industry stakeholders.
Tune in and learn how data analytics can transform your approach to drug development!
Fast Track Your Business Growth:
Outcomes Rocket is a full service marketing agency focused on helping healthcare organizations like yours maximize your impact and accelerate growth. Learn more at outcomesrocket.com
More shows like Outcomes Rocket
View all
Radiolab
43,890 Listeners
TED Talks Daily
11,177 Listeners
Stuff You Should Know
77,377 Listeners
Freakonomics Radio
31,896 Listeners
Making Sense with Sam Harris
26,317 Listeners
Pivot
8,928 Listeners
The Daily
111,077 Listeners
Up First from NPR
55,962 Listeners
KFF Health News' 'What the Health?'
472 Listeners
GZERO World with Ian Bremmer
730 Listeners
TRIGGERnometry
1,805 Listeners
The Peter Attia Drive
7,871 Listeners
Fiction - Comedy Fiction
6,442 Listeners
The Prof G Pod with Scott Galloway
5,219 Listeners
Huberman Lab
28,406 Listeners